| | Hang Seng Index | 26.200 HKD | -0.260 | -0.983% | 788.45M | 20.68B | 26.473 (-1.031%) HKD as at 2026/04/22 | | |
| | Hang Seng China Enterprises Index | 89.380 HKD | -0.800 | -0.887% | 108.50M | 9.70B | 90.148 (-0.852%) HKD as at 2026/04/22 | | |
| | Hang Seng TECH Index | 4.758 HKD | -0.100 | -2.058% | 1.40B | 6.69B | 4.955 (-3.966%) HKD as at 2026/04/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | SK hynix Inc. | 42.500 HKD | -0.720 | -1.666% | 76.25M | 3.22B | 42.806 (-0.714%) HKD as at 2026/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Samsung Electronics Co Ltd | 92.760 HKD | +3.760 | +4.225% | 14.31M | 1.34B | 89.212 (+3.978%) HKD as at 2026/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 3.778 HKD | -0.166 | -4.209% | 309.69M | 1.18B | 3.943 (-4.187%) HKD as at 2026/04/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.712 HKD | +0.070 | +4.263% | 287.86M | 490.24M | 1.647 (+3.978%) HKD as at 2026/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.875 HKD | -0.125 | -2.083% | 43.66M | 256.66M | 5.985 (-1.836%) HKD as at 2026/04/22 | | |
| | Hang Seng TECH Index (net total return version) | 10.220 HKD | -0.230 | -2.201% | 23.73M | 242.92M | 10.634 (-3.889%) HKD as at 2026/04/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 1.714 HKD | +0.034 | +2.024% | 106.64M | 182.62M | 1.684 (+1.781%) HKD as at 2026/04/22 | | |
| | FTSE China A50 Index | 17.290 HKD | +0.030 | +0.174% | 9.71M | 167.46M | 17.184 (+0.619%) HKD as at 2026/04/21 | | |
| | CSI 300 Index | 56.920 HKD | -0.280 | -0.490% | 2.46M | 139.79M | 56.820 (+0.175%) HKD as at 2026/04/21 | | |
| | Hang Seng TECH Index | 4.848 HKD | -0.104 | -2.100% | 22.63M | 109.86M | 4.945 (-1.970%) HKD as at 2026/04/22 | | |
| | | 9.655 HKD | -0.010 | -0.103% | 11.16M | 107.74M | 9.657 (-0.023%) HKD as at 2026/04/21 | | |
| | Hang Seng Biotech Index | 14.850 HKD | -0.660 | -4.255% | 6.68M | 100.61M | 15.528 (-4.363%) HKD as at 2026/04/22 | | |
| | London Gold Fixing Price | 3,425.000 HKD | +4.000 | +0.117% | 25.65K | 86.94M | 442.100 (-1.085%) USD as at 2026/04/20 | | |
| | Hang Seng High Dividend 30 Index (price return version) | 21.640 HKD | +0.160 | +0.745% | 4.05M | 86.80M | 21.407 (+1.087%) HKD as at 2026/04/22 | | |
| | | 8.210 HKD | -0.005 | -0.061% | 10.40M | 85.41M | 8.208 (+0.026%) HKD as at 2026/04/21 | | |
| | FTSE China A50 Index | 15.960 HKD | +0.040 | +0.251% | 5.16M | 82.31M | 15.920 (+0.254%) HKD as at 2026/04/21 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 29.260 HKD | -0.520 | -1.746% | 2.30M | 66.79M | 29.034 (+0.780%) HKD as at 2026/04/21 | | |
| | | 10.450 HKD | -0.060 | -0.571% | 4.64M | 48.44M | 10.552 (-0.963%) HKD as at 2026/04/21 | | |
| | Hang Seng High Dividend Yield Index | 32.680 HKD | 0.000 | 0.000% | 1.47M | 48.05M | 33.048 (-1.113%) HKD as at 2026/04/21 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 2.872 HKD | -0.034 | -1.170% | 10.26M | 29.50M | 2.951 (-2.664%) HKD as at 2026/04/21 | | |
| | S&P GSCI Crude Oil Multiple Contract 55/30/15 1M/2M/3M (USD) ER Index | 10.100 HKD | +0.325 | +3.325% | 2.56M | 25.93M | 9.815 (+2.907%) HKD as at 2026/04/21 | | |
| | | 8.000 HKD | -0.010 | -0.125% | 2.86M | 22.86M | 8.019 (-0.231%) HKD as at 2026/04/21 | | |
| | FactSet Asia Semiconductor Index (net total return) | 134.950 HKD | -0.650 | -0.479% | 166.78K | 22.42M | 133.255 (+1.272%) HKD as at 2026/04/21 | | |
| | London Gold Fixing Price | 22.280 HKD | -0.220 | -0.978% | 818.86K | 18.22M | 22.434 (-0.685%) HKD as at 2026/04/22 | | |
| | Hang Seng Biotech Index | 3.542 HKD | -0.150 | -4.063% | 4.55M | 16.22M | 3.731 (-5.076%) HKD as at 2026/04/21 | | |
| | Bloomberg APAC High Dividend 40 Net Return Index HKD | 14.840 HKD | -0.120 | -0.802% | 1.02M | 15.14M | 14.774 (+0.445%) HKD as at 2026/04/21 | | |
| | MSCI All Country Asia ex Japan Index | 83.440 HKD | +1.160 | +1.410% | 163.89K | 13.47M | 82.468 (+1.178%) HKD as at 2026/04/21 | | |